Table 1. Participant demographics for each group within each trial.
| Characteristic | Trial 1 | Trial 2 | ||
|---|---|---|---|---|
| Current weekend service | No weekend service | No weekend service | Newly developed weekend service | |
| N | 8,038 | 6,796 | 6,869 | 5,805 |
| Age (years)—mean (SD) | 59.5 (20.7) | 60.8 (20.2) | 59.7 (20.6) | 59.8 (20.3) |
| Sex—n (%) male | 4,225 (53.6%) | 3,611 (53.1%) | 3,587 (52.2%) | 3,090 (53.2%) |
| Most common Australian Refined Diagnosis Related Groups—n (%) | Other digestive system disorders, 267 (3.3%); respiratory infections and inflammations, 214 (2.6%); heart failure and shock, 211 (2.6%); chronic obstructive airways disease, 208 (2.6%) | Chronic obstructive airways disease, 250 (3.7%); respiratory infections and inflammations, 248 (3.7%); other digestive system disorders, 202 (3.0%); septicaemia, 192 (2.8%) | Other digestive system disorders, 237 (3.5%); septicaemia, 198 (2.9%); chronic obstructive airways disease, 179 (2.6%); respiratory infections and inflammations, 178 (2.6%) | Other digestive system disorders, 194 (3.3%); chronic obstructive airways disease, 162 (2.8%); respiratory infections and inflammations, 153 (2.6%); laprascopic cholecystectomy, 145 (2.4%) |
| Expected length of stay (days)*—mean (SD) | 5.3 (5.1) | 5.7 (5.1) | 5.0 (4.5) | 5.4 (5.6) |
*Based on mean inlier Australian Refined Diagnosis Related Groups from Victoria in 2013.